Roy L. McQuinn

696 total citations
25 papers, 517 citations indexed

About

Roy L. McQuinn is a scholar working on Pharmacology, Analytical Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Roy L. McQuinn has authored 25 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Analytical Chemistry and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Roy L. McQuinn's work include Analytical Methods in Pharmaceuticals (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Roy L. McQuinn is often cited by papers focused on Analytical Methods in Pharmaceuticals (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Roy L. McQuinn collaborates with scholars based in United States, Canada and United Kingdom. Roy L. McQuinn's co-authors include S.Y. Yeh, Charles W. Gorodetzky, Edward J. Cone, H E Shannon, Gordon J. Conard, Richard T. Smith, James C. Perry, Arthur Garson, John Walls and Anthony Williams and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Controlled Release and Journal of Medicinal Chemistry.

In The Last Decade

Roy L. McQuinn

25 papers receiving 487 citations

Peers

Roy L. McQuinn
Carole Bye United Kingdom
Richard A. Okerholm United States
William Schary United States
Ram P. Kapil United States
M. Guerret France
T E Gaffney United States
A. Gérardin Switzerland
M. Gerna Italy
John A. Ziemniak United States
Carole Bye United Kingdom
Roy L. McQuinn
Citations per year, relative to Roy L. McQuinn Roy L. McQuinn (= 1×) peers Carole Bye

Countries citing papers authored by Roy L. McQuinn

Since Specialization
Citations

This map shows the geographic impact of Roy L. McQuinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy L. McQuinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy L. McQuinn more than expected).

Fields of papers citing papers by Roy L. McQuinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy L. McQuinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy L. McQuinn. The network helps show where Roy L. McQuinn may publish in the future.

Co-authorship network of co-authors of Roy L. McQuinn

This figure shows the co-authorship network connecting the top 25 collaborators of Roy L. McQuinn. A scholar is included among the top collaborators of Roy L. McQuinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy L. McQuinn. Roy L. McQuinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beneš, Luděk, et al.. (1997). Transmucosal, Oral Controlled-Release, and Transdermal Drug Administration in Human Subjects: A Crossover Study with Melatonin. Journal of Pharmaceutical Sciences. 86(10). 1115–1119. 72 indexed citations
2.
McQuinn, Roy L., et al.. (1995). Sustained oral mucosal delivery in human volunteers of buprenorphine from a thin non-eroding mucoadhesive polymeric disk. Journal of Controlled Release. 34(3). 243–250. 25 indexed citations
3.
McQuinn, Roy L., et al.. (1990). Flecainide excretion in human breast milk. Clinical Pharmacology & Therapeutics. 48(3). 262–267. 12 indexed citations
4.
Perry, James C., et al.. (1989). Flecainide acetate for resistant arrhythmias in the young: Efficacy and pharmacokinetics. Journal of the American College of Cardiology. 14(1). 185–191. 69 indexed citations
5.
Holtzman, Jordan L., Denise Finley, Donald A. Berry, et al.. (1989). The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: Effects on cardiac function and drug clearance. Clinical Pharmacology & Therapeutics. 46(1). 26–32. 18 indexed citations
6.
Williams, Anthony, Roy L. McQuinn, & John Walls. (1988). Pharmacokinetics of flecainide acetate in patients with severe renal impairment. Clinical Pharmacology & Therapeutics. 43(4). 449–455. 31 indexed citations
7.
Szabó, Tibor, Douglas L. Jones, Roy L. McQuinn, & George J. Klein. (1988). Flecainide Acetate Does Not Alter the Energy Requirements for Direct Ventricular Defibrillation Using Sequential Puise Defibrillation in Pigs. Journal of Cardiovascular Pharmacology. 12(4). 377–383. 21 indexed citations
8.
McQuinn, Roy L., et al.. (1988). High-performance liquid chromatographic procedure with fluorescence detection for the m-O-dealkylated lactam metabolite of flecainide acetate in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 431(2). 438–443. 2 indexed citations
9.
McQuinn, Roy L., P J Pentikäinen, Stephen Chang, & Gordon J. Conard. (1988). Pharmacokinetics of flecainide in patients with cirrhosis of the liver. Clinical Pharmacology & Therapeutics. 44(5). 566–572. 24 indexed citations
10.
Cutler, Ralph E., et al.. (1988). Flecainide Pharmacokinetics After Multiple Dosing in Patients with Impaired Renal Function. The Journal of Clinical Pharmacology. 28(8). 727–735. 17 indexed citations
11.
McQuinn, Roy L., et al.. (1985). High-performance liquid chromatographic method for the quantitation of a meta-O-dealkylated metabolite of flecainide acetate, a new antiarrhythmic. Journal of Chromatography B Biomedical Sciences and Applications. 343(1). 119–127. 7 indexed citations
12.
McQuinn, Roy L., et al.. (1984). Biotransformation and elimination of 14C-flecainide acetate in humans.. Drug Metabolism and Disposition. 12(4). 414–420. 44 indexed citations
13.
Cone, Edward J., Roy L. McQuinn, & H E Shannon. (1984). Structure-activity relationship studies of phencyclidine derivatives in rats.. Journal of Pharmacology and Experimental Therapeutics. 228(1). 147–153. 36 indexed citations
14.
Shannon, H E, Roy L. McQuinn, D. Bruce Vaupel, & Edward J. Cone. (1983). Effects of cycloalkyl ring analogs of phencyclidine on behavior in rodents.. Journal of Pharmacology and Experimental Therapeutics. 224(2). 327–333. 6 indexed citations
15.
McQuinn, Roy L., et al.. (1982). Distribution of 13N in rat tissues following intravenous administration of nitroso-labeled BCNU. Cancer Chemotherapy and Pharmacology. 10(1). 16–21. 9 indexed citations
16.
McQuinn, Roy L., Edward J. Cone, Harlan E. Shannon, & Tsung‐Ping Su. (1981). Structure-activity relationships of the cycloalkyl ring of phencyclidine. Journal of Medicinal Chemistry. 24(12). 1429–1432. 11 indexed citations
17.
Jasinski, Donald R., et al.. (1980). Interdisciplinary studies on phencyclidine at the Addiction Research Center, Lexington, Kentucky [proceedings].. PubMed. 16(4). 79–81. 3 indexed citations
18.
Yeh, S.Y., Roy L. McQuinn, & Charles W. Gorodetzky. (1977). Identification of Diacetylmorphine Metabolites in Humans. Journal of Pharmaceutical Sciences. 66(2). 201–204. 23 indexed citations
19.
Yeh, S.Y., Roy L. McQuinn, & Charles W. Gorodetzky. (1977). Biotransformation of morphine to dihydromorphinone and normorphine in the mouse, rat, rabbit, guinea pig, cat, dog, and monkey.. Drug Metabolism and Disposition. 5(4). 335–342. 24 indexed citations
20.
Yeh, S.Y., Charles W. Gorodetzky, & Roy L. McQuinn. (1976). Urinary excretion of heroin and its metabolites in man.. Journal of Pharmacology and Experimental Therapeutics. 196(2). 249–256. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026